• Users Online: 569
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli

Iacobino Angelo, Piccaro Giovanni, Giannoni Federico, Mustazzolu Alessandro, Fattorini Lanfranco

Year : 2017| Volume: 6| Issue : 3 | Page no: 213-221

   This article has been cited by
1 Drug-Resistant Tuberculosis 2020: Where We Stand
Angelo Iacobino,Lanfranco Fattorini,Federico Giannoni
Applied Sciences. 2020; 10(6): 2153
[Pubmed]  [Google Scholar] [DOI]
2 Molecule Property Analyses of Active Compounds for Mycobacterium Tuberculosis
Vadim Makarov,Elena Salina,Robert C. Reynolds,Phyo Phyo Kyaw Zin,Sean Ekins
Journal of Medicinal Chemistry. 2020;
[Pubmed]  [Google Scholar] [DOI]
3 A rapid, low pH, nutrient stress, assay to determine the bactericidal activity of compounds against non-replicating Mycobacterium tuberculosis
Julie V. Early,Steven Mullen,Tanya Parish,Adelaide Almeida
PLOS ONE. 2019; 14(10): e0222970
[Pubmed]  [Google Scholar] [DOI]
4 Novel MenA Inhibitors Are Bactericidal against Mycobacterium tuberculosis and Synergize with Electron Transport Chain Inhibitors
Bryan J. Berube,Dara Russell,Lina Castro,Seoung-ryoung Choi,Prabagaran Narayanasamy,Tanya Parish
Antimicrobial Agents and Chemotherapy. 2019; 63(6)
[Pubmed]  [Google Scholar] [DOI]
5 Modeling of Mycobacterium tuberculosis dormancy in bacterial cultures
Yana R. Batyrshina,Yakov Sh Schwartz
Tuberculosis. 2019; 117: 7
[Pubmed]  [Google Scholar] [DOI]
6 Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidence
Saif Khan,Raju K. Mandal,Abdulbaset Mohamed Elasbali,Sajad A. Dar,Arshad Jawed,Mohd Wahid,Harishankar Mahto,Mohtashim Lohani,Bhartendu Nath Mishra,Naseem Akhter,Ali A. Rabaan,Shafiul Haque
Bioscience Reports. 2019; 39(1)
[Pubmed]  [Google Scholar] [DOI]
7 Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients
Michael A. Lyons
Antimicrobial Agents and Chemotherapy. 2019; 63(12)
[Pubmed]  [Google Scholar] [DOI]
8 The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH
Angelo Iacobino,Federico Giannoni,Manuela Pardini,Giovanni Piccaro,Lanfranco Fattorini
Antimicrobial Agents and Chemotherapy. 2019; 63(7)
[Pubmed]  [Google Scholar] [DOI]
9 Development and biological evaluation of a new nanotheranostic for tuberculosis
Edward Helal-Neto,Suyene Rocha Pinto,Filipe Leal Portilho,Marcellus Dias da Costa,Jonathas Xavier Pereira,Fiammetta Nigro,Eduardo Ricci-Junior,Andre Luis Peixoto Candéa,Maria das Graças Muller de Oliveira Henri,Ralph Santos-Oliveira
Drug Delivery and Translational Research. 2018;
[Pubmed]  [Google Scholar] [DOI]
10 Activity of DNA-targeted C8-linked pyrrolobenzodiazepine–heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions
Angelo Iacobino,Federico Giannoni,Lanfranco Fattorini,Federico Brucoli
The Journal of Antibiotics. 2018;
[Pubmed]  [Google Scholar] [DOI]


Read this article